• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comparative analysis of in-hospital outcomes between spontaneous vertebral and carotid arterial dissection at National level (P5.048)
Conclusions:Vertebral artery dissection affects younger patients in comparison to carotid dissections, is associated with higher in hospital complications and procedures, probably thereby leading to prolonged length of stay and higher hospital charges in comparison with carotid artery dissection. Early diagnoses of vertebral artery dissection as a cause of ischemic stroke in the posterior circulation is imperative to improve outcomes.Disclosure: Dr. Qureshi has nothing to disclose. Dr. Afzal has nothing to disclose. Dr. Qureshi has nothing to disclose. Dr. Khatri has nothing to disclose. Dr. Piriyawat has nothing to disclo...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Qureshi, I., Afzal, M.-R., Qureshi, M., Khatri, R., Piriyawat, P., Rodriguez, G., Cruz-Flores, S., Maud, A. Tags: Neurocritical Care: Ischemic Injury Source Type: research

Intermediate-term rates of stroke following cardiac procedures: the Nationwide Readmissions Database (P4.305)
Conclusions:Using a large, nationally representative database of inpatient admissions from 2013, we found that 90-day stroke rates are higher after cardiac procedures compared to non-cardiac procedures and non-surgical admissions. However, these rates are likely lower than previously reported.Disclosure: Dr. Stein has nothing to disclose. Dr. Thaler has nothing to disclose. Dr. Liang has nothing to disclose. Dr. Tuhrim has nothing to disclose. Dr. Dhamoon has nothing to disclose. Dr. Dhamoon has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Stein, L., Thaler, A., Liang, J., Tuhrim, S., Dhamoon, A., Dhamoon, M. Tags: Neuroepidemiology: Cerebrovascular Disease I Source Type: research

Utilization of Carotid Revascularization for Ischemic Stroke/TIA: A Canadian Perspective (P5.276)
Conclusions:Use of CEA/CAS in patients with acute ischemic stroke/TIA admitted to hospitals in Canada has doubled over the last decade. Differences in utilization by age, sex and across provinces are seen.Disclosure: Dr. Najm has nothing to disclose. Dr. Lindsay has nothing to disclose. Dr. Hill has nothing to disclose. Dr. Demchuk has nothing to disclose. Dr. Menon has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Najm, M., Lindsay, P., Hill, M. D., Demchuk, A., Menon, B. Tags: SubAcute Interventional Therapies in Cerebrovascular Disease Source Type: research

Left ventricular wall motion abnormalities: What can they tell us about stroke recurrence?
Left ventricular wall motion abnormalities (LVWMAs) are commonly observed in a variety of medical conditions, including coronary artery disease, congestive heart failure, stress-induced cardiomyopathy, myocarditis, chronic renal disease, and stroke.1–4 Their underlying disease mechanisms and their potential causative role for stroke remain inadequately elucidated. LVWMAs may directly increase stroke risk through thrombus formation in the left ventricle5 or may merely indicate the burden of systemic atherosclerosis underlying stroke, and not the primum movens.
Source: Neurology - February 5, 2017 Category: Neurology Authors: Brouns, R. Tags: Cardiac, Embolism, Infarction EDITORIALS Source Type: research

Atrial Fibrillations Effect on the Rate of Ischemic Stroke, Death and Disability in Subarachnoid Hemorrhage (P1.256)
Conclusion: There are significantly decreased rates of favorable outcomes in subarachnoid hemorrhage patients with atrial fibrillation. Further studies are warranted to better understand the associated factors.Disclosure: Dr. Hassan has nothing to disclose. Dr. Afzal has nothing to disclose. Dr. Chaudhry has nothing to disclose. Dr. Sanchez has nothing to disclose. Dr. Sanchez has nothing to disclose. Dr. Tekle has nothing to disclose. Dr. Qureshi has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Hassan, A., Afzal, M. R., Chaudhry, S., Sanchez, C., Sanchez, C., Tekle, W., Qureshi, A., Riaz, A. Tags: Aneurysms and Subarachnoid Hemorrhage Source Type: research

Pregnancy in Advanced Age Increases the Risk of Hemorrhagic Stroke in Post-Menopausal Women. Analysis of Women's Health Initiative Study (P6.005)
Conclusions: Women with pregnancy in advanced age have a higher risk for hemorrhagic stroke in post-menopausal period.Disclosure: Dr. Qureshi has nothing to disclose. Dr. Saeed has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Degenhardt has nothing to disclose. Dr. Axt-Fliedner has nothing to disclose. Dr. Kohl has nothing to disclose. Dr. Suri has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Qureshi, A., Saeed, O., Malik, A., Degenhardt, J., Axt-Fliedner, R., Kohl, T., Suri, M. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research

Symptomatic Intracranial Hemorrhage Rates and Intravenous Tissue Plasminogen Activator Treatment Time Windows: Does Treatment Window Make a Difference? (P6.015)
Conclusions: tPA treatment windows impact sICH, mortality and favorable discharge rates. Ensuring tPA is received <3h is vital for patients suffering an ischemic stroke.Disclosure: Dr. Wagner has received personal compensation for activities with Genentech, Inc., as a speakers bureau member. Dr. Orlando has nothing to disclose. Dr. Fanale has received personal compensation for activities with Genentech, Inc as a speaker. Dr. McCarthy has nothing to disclose. Dr. Whaley has received personal compensation for activities with Clinical Data Management/Neurobase and Genentech. Dr. Jensen has nothing to disclose. Dr. Bar-Or h...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Wagner, J., Orlando, A., Fanale, C., McCarthy, K., Whaley, M., Jensen, J., Bar-Or, D. Tags: Cerebrovascular Disease and Interventional Neurology ePoster Session Source Type: research

Risk Factors for Blood-Brain Barrier Disruption in Patients with Chronic Cerebrovascular Disease Presenting with Acute Stroke (P2.245)
Conclusions: These findings suggest that cWMD caused by chronic hypertension may have a different underlying pathophysiology than cWMD that is associated with aging.Disclosure: Dr. Gupta has nothing to disclose. Dr. Luby has nothing to disclose. Dr. Nadareishvili has nothing to disclose. Dr. Benson has nothing to disclose. Dr. Hsia has nothing to disclose. Dr. Lynch has nothing to disclose. Dr. Leigh has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Gupta, N., Luby, M., Nadareishvili, Z., Benson, R., Hsia, A., Lynch, J., Leigh, R. Tags: Aging and Dementia: Other Source Type: research

Photoplythesmographic Signal to Screen Sleep-Disordered Breathing in Acute Stroke Patients: Feasibility of a Prospective Clinical Pathway (P1.181)
Conclusions: Screening hospitalized patients admitted for acute stroke with a positive questionnaire and inpatient plythesmography may identify a cohort of patients with high prevalence SDB. Our screening strategy hypothesizes that inpatient ODI can be a potentially cost-effective method for early recognition of SDB in acute stroke patients.Disclosure: Dr. Lim-Hing has nothing to disclose. Dr. Byrne has nothing to disclose. Dr. Yaddanapudi has nothing to disclose. Dr. Pineda has nothing to disclose. Dr. Sharma has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Lim-Hing, K., Byrne, R., Yaddanapudi, S., Pineda, C., Sharma, S. Tags: Cerebrovascular Disease: Risk Factors and Prevention Source Type: research

Association of Hemoglobin A1c and Baseline Ischemic Stroke Severity: A Population-Based Study (P1.187)
Conclusions: We found that elevated HbA1c was associated with decreased stroke severity at presentation. However, this effect is mediated by the history of DM rather than a specific dose-effect of glycemic control. Our results provide evidence that although chronic hyperglycemia increases risk of stroke, it is not associated with increased stroke severity.Disclosure: Dr. Yang has nothing to disclose. Dr. Khoury has nothing to disclose. Dr. Alwell has nothing to disclose. Dr. Moomaw has received research support from the National Institutes of Health. Dr. Yeramaneni has nothing to disclose. Dr. Woo has received research sup...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Yang, Y., Khoury, J., Alwell, K., Moomaw, C., Yeramaneni, S., Woo, D., Flaherty, M., Adeoye, O., Ferioli, S., De Los Rios La Rosa, F., Kissela, B., Kleindorfer, D. Tags: Ischemic Stroke Outcomes Source Type: research

Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF
Conclusion: Increasing age and a prolonged PR interval at enrollment were independently associated with an increased AF incidence in CS patients. However, they offered only moderate predictive ability in determining which CS patients had AF detected by the ICM.
Source: Neurology - January 18, 2016 Category: Neurology Authors: Thijs, V. N., Brachmann, J., Morillo, C. A., Passman, R. S., Sanna, T., Bernstein, R. A., Diener, H.-C., Di Lazzaro, V., Rymer, M. M., Hogge, L., Rogers, T. B., Ziegler, P. D., Assar, M. D. Tags: Stroke prevention, Prognosis, All Cerebrovascular disease/Stroke, Clinical trials Randomized controlled (CONSORT agreement), Risk factors in epidemiology ARTICLE Source Type: research

Endovascular vs medical management of acute ischemic stroke
Conclusions: This meta-analysis provides strong evidence that endovascular intervention combined with medical management, including IV tissue plasminogen activator for eligible patients, improves the outcomes of appropriately selected patients with acute ischemic stroke in the setting of LVO.
Source: Neurology - November 30, 2015 Category: Neurology Authors: Chen, C.-J., Ding, D., Starke, R. M., Mehndiratta, P., Crowley, R. W., Liu, K. C., Southerland, A. M., Worrall, B. B. Tags: All Clinical trials, All Cerebrovascular disease/Stroke, Class I, Infarction, Intracerebral hemorrhage VIEWS & amp;amp; REVIEWS Source Type: research

Atrial Fibrillation in Patients with Neuropathological Diagnosis of Primary Alzheimer's Disease (I9-5A)
CONCLUSIONS: AF-AD has a more "vascular" and "benign" profile than nAF-AD. Dementia seems to be mediated by brain infarcts rather than by neurodegeneration. FUNDING:National Institute on Aging (UO1 AG016976).Disclosure: Dr. Riccio has nothing to disclose. Dr. Sposato has nothing to disclose. Dr. Ruiz Vargas has nothing to disclose. Dr. Toledo has nothing to disclose. Dr. Trojanowski has received personal compensation for activities with Johnson & Johnson. Dr. Hachinski has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Riccio, P., Sposato, L. A., Ruiz Vargas, E., Toledo, J., Trojanowski, J., Hachinski, V. Tags: Treating Dementia in an Age of Mixed Disease Poster Presentations Source Type: research

Risk of ischemic stroke during periods of warfarin discontinuation for surgical procedures: A longitudinal study of 4060 patients with atrial fibrillation (P1.058)
CONCLUSIONS: The risk associated with discontinuation of warfarin for procedures must be recognized and considered in the risk benefit analysis of any procedure.Disclosure: Dr. Jahangir has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Suri has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Jahangir, N., Malik, A., Suri, M., Qureshi, A. Tags: Cerebrovascular Disease and Interventional Neurology: Atrial Fibrillation and Cardio-embolic Stroke Source Type: research

Are there Different Rates of Acute Stroke Risk Factors in the South Texas Mexican American population? (P7.146)
CONCLUSION: In the South Texas Mexican American AIS population, there is greater then a three-fold higher prevalence of hypertension, diabetes and CHF compared with Hispanics/Latinos in the US. AFIB and CHF are significant predictors of poor outcome in this unique population.Disclosure: Dr. Tekle has nothing to disclose. Dr. Hassan has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Jones-Fullingim has nothing to disclose. Dr. Sanchez has nothing to disclose. Dr. Jani has nothing to disclose. Dr. Sanchez has nothing to disclose. Dr. Abantao has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Tekle, W., Hassan, A., Malik, A., Jones-Fullingim, L., Sanchez, C., Jani, V., Sanchez, O., Abantao, E., Qureshi, A. Tags: Cerebrovascular Disease and Interventional Neurology: Race, Ethnicity, and Stroke Source Type: research

Pages: 1  2